Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer

This study has been completed.
Sponsor:
Collaborator:
PPD
Information provided by:
Threshold Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00102752
First received: February 1, 2005
Last updated: April 28, 2009
Last verified: April 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2007
  Primary Completion Date: July 2007 (Final data collection date for primary outcome measure)